Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Biotech Launches With $61M In Funding To Fight Cancer Relapse, Metastasis
Venture Capital

Biotech Launches With $61M In Funding To Fight Cancer Relapse, Metastasis

by crainsnewyork.com posted 2months ago 50 views
Manhattan-based biotechnology company HiberCell launched Thursday, buoyed by a nearly $60.8 million Series A round led by ARCH Venture Partners. HiberCell is developing therapeutics to target what... To view the full story, click the title link.